HAE
Haemonetics Corporation
NYSE: HAE · HEALTHCARE · MEDICAL DEVICES
$52.67
-5.30% today
Updated 2026-05-06
Market cap
$2.75B
P/E ratio
16.33
P/S ratio
2.09x
EPS (TTM)
$3.63
Dividend yield
—
52W range
$47 – $87
Volume
0.7M
Haemonetics Corporation (HAE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $85.62M | $83.56M | $77.67M | $116.36M | $130.67M | $123.45M | $115.32M | $85.07M | $139.52M | $127.18M | $121.86M | $159.74M | $220.35M | $159.28M | $158.22M | $108.81M | $172.26M | $273.06M | $181.75M | $181.72M |
| Capital expenditures | $36.77M | $41.46M | $57.79M | $56.38M | $56.30M | $46.67M | $53.20M | $62.19M | $73.65M | $122.22M | $102.41M | $76.14M | $74.80M | $118.96M | $48.76M | $37.04M | $96.51M | $110.19M | $66.30M | $39.28M |
| Depreciation | $25.15M | $27.50M | $31.20M | $36.46M | $43.24M | $48.15M | $49.97M | $65.48M | $81.74M | $86.05M | $90.03M | $89.73M | $89.25M | $109.42M | $110.29M | $84.29M | $97.75M | $93.31M | $97.22M | $115.59M |
| Stock-based comp | — | $10.25M | $222000.00 | $10.18M | $10.27M | $10.81M | $9.29M | $10.97M | $13.08M | $14.10M | $6.95M | $9.15M | $13.03M | $17.19M | $20.45M | $25.52M | $24.36M | $25.58M | $28.33M | $29.64M |
| Free cash flow | $48.84M | $42.10M | $19.88M | $59.98M | $74.36M | $76.79M | $62.12M | $22.89M | $65.88M | $4.96M | $19.46M | $83.60M | $145.55M | $40.32M | $109.46M | $71.77M | $75.75M | $162.87M | $115.45M | $142.45M |
| Investing cash flow | $-32.10M | $-71.12M | $-102.85M | $-60.00M | $-132.34M | $-51.56M | $-52.20M | $-596.39M | $-105.83M | $-121.77M | $-104.77M | $-73.31M | $-63.04M | $-116.15M | $-57.18M | $-425.44M | $-86.34M | $-143.79M | $-322.39M | $-161.90M |
| Financing cash flow | $12.09M | $-35.55M | $-73.23M | $-30.74M | $-13.97M | $-18.08M | $-30.47M | $461.85M | $-20.70M | $-33.16M | $-62.62M | $-60.41M | $-120.64M | $-50.63M | $-131.21M | $367.45M | $-15.75M | $-100.36M | $38.16M | $108.82M |
| Dividends paid | — | — | — | — | — | $0.00 | $15.19M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $13.45M | $12.02M | — | — | $7.02M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $55.15M | $32.15M | $-49.74M | $13.35M | $-31.81M | $-45.54M | $24.44M | $40.60M | $-10.82M | $-30.17M | $50.81M | $70.17M | $28.91M | — | — |